Physician profile
James Chung
NPI 1528598281
$22,879.28
in general payments reported to CMS, 2019-2025
36 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $484 · 2021: $1,471 · 2022: $813 · 2023: $940 · 2024: $3,445 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $2,761 · Food and Beverage: $2,241 · Honoraria: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,420.00 |
| Travel and Lodging | $2,760.91 |
| Food and Beverage | $2,240.53 |
| Honoraria | $1,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $13,916.89 | 2025 | |
| Novastep INC. | $1,545.76 | 2024-2025 | Nexis |
| Ortho Solutions INC | $1,405.00 | 2024 | |
| Exactech, INC. | $1,308.41 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $1,089.36 | 2019-2021 | |
| Stryker Corporation | $1,016.83 | 2020-2025 | Easyfuse, Augment Injectable, Axs Infinity Ls |
| International Life Sciences | $349.26 | 2023-2024 | Flexband |
| Paratek Pharmaceuticals, INC. | $315.08 | 2021-2024 | Nuzyra |
| Smith+Nephew, INC. | $286.66 | 2019-2024 | Grafix |
| Horizon Therapeutics Plc | $228.79 | 2020-2022 | |
| Heron Therapeutics, INC. | $151.50 | 2022 | |
| Integra Lifesciences Corporation | $125.27 | 2019-2023 | Tenoglide |
| Osiris Therapeutics INC. | $112.93 | 2019 | |
| In2bones USA, LLC | $110.13 | 2022 | |
| Hikma Pharmaceuticals USA | $86.97 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $78.45 | 2024 | Affinity |
| Depuy Synthes Sales INC. | $74.62 | 2019-2024 | Na |
| Bioventus LLC | $67.15 | 2021-2022 | |
| Convatec INC. | $66.38 | 2023 | |
| Nevro Corp. | $65.72 | 2024 | Senza |
| Trice Medical, INC. | $63.07 | 2022 | |
| Supreme Orthopedic Systems, LLC | $49.92 | 2025 | |
| Biocomposites INC | $47.95 | 2025 | Stimulan |
| Sebela Pharmaceuticals INC. | $42.57 | 2022 | |
| Ermi LLC | $38.88 | 2022 | |
| Medshape, INC. | $35.42 | 2023 | Dynanail |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.39 | 2021-2022 | |
| Orthofix Medical, INC. | $29.19 | 2021-2025 | Physio-Stim |
| Acumed LLC | $24.12 | 2024 | Acumed |
| Triad Life Sciences INC. | $22.85 | 2022 | |
| Anika Therapeutics, INC. | $18.31 | 2022 | |
| Ossio INC | $16.49 | 2021 | |
| Kci USA, INC. | $15.65 | 2023 | V.A.C. Dermatac, Activ.A.C., V.A.C. Veraflo |
| Collegium Pharmaceutical, INC. | $13.57 | 2021 | |
| Medtronic, INC. | $13.38 | 2023 | Intellis Adaptivestim |
| Kerecis Limited | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.